Latar belakang: Polimorfisme Gly972Arg pada gen IRS1 dapat mengganggu
fungsi normal endotel dan menyebabkan disfungsi endotel. TIMI flow pasca
prosedur IKPP dan jumlah pembuluh darah yang terlibat pada pasien IMA-EST
merupakan prediktor mortalitas dan morbiditas selama perawatan. Mekanisme
yang menyebabkan adanya perbedaan profil angiografi ini salah satunya
dipengaruhi oleh difungsi endotel di tingkat mikrovaskular dan makrovaskular.
Penelitian mengenai hubungan antara polimorfisme Gly972Arg pada gen IRS1
dengan TIMI flow pasca prosedur dan jumlah keterlibatan pembuluh darah belum
pernah dilakukan.
Tujuan: Penelitian ini bertujuan untuk mengetahui hubungan antara polimorfisme
Gly972Arg pada IRS1 dengan TIMI flow pasca IKPP dan jumlah keterlibatan
pembuluh darah pada pasien IMA-EST.
Metode: Studi potong lintang pada 104 pasien IMA-EST RSJPDHK yang
menjalani IKPP yang masuk pada registri 2018. Pemeriksaan polimorfisme
Gly972Arg pada IRS1 dengan menggunakan metode Taqman.
Hasil: Terdapat 104 subjek yang diikutsertakan dalam penelitian ini. Subjek dibagi
dalam 3 kelompok, yakni grup wildtype/CC (42,3%), heterozigot/CT (49,0%), dan
homozigot mutan/TT (8,7%). Tidak terdapat hubungan yang bermakna antara
kelompok mutan (TT) dengan TIMI flow pasca IKPP (OR 0,8; p = 1,000) dan
jumlah keterlibatan pembuluh darah (OR 0,3; p = 0,163).
Kesimpulan: Tidak terdapat hubungan antara polimorfisme Gly972Arg gen IRS1
dengan TIMI flow pasca IKPP dan jumlah keterlibatan pembuluh darah pasien IMA
EST.
Background: Gly972Arg polymorphism of IRS1 gene can interfere with normal
endothelial function and cause endothelial dysfunction. TIMI flow after the primary
percutaneous intervention procedure and the number of coronary vessels involved
in STEMI patients are predictors that determine mortality and morbidity during
treatment. The mechanism that causes this difference in angiographic profile is
influenced by endothelial dysfunction at the microvascular and macrovascular
levels. Research on the relationship between Gly972Arg polymorphisms of IRS1
gene with TIMI flow post procedure and the amount of blood vessel involvement
has not been carried out.
Objective: We sought to define whether Gly972Arg polymorphisms of IRS1 gene
may affect TIMI flow after primary percutaneous intervention and number of
coronary vessel involved.
Methods: Cross-sectional study design of 104 STEMI patients who underwent
primary PCI at National Cardiovascular Center Harapan Kita Hospital at year 2018.
Examination of Gly972Arg polymorphism on IRS1 is using the Taqman method
PCR.
Results: There were 104 of STEMI patients who underwent primary PCI and
recruited for the study. The subjects then divided into 3 categories, which are
wildtype/CC (42,3%), carrier/CT (49,0%) and mutant/TT (8,7%). There were no
significant relationship between the mutant group (TT) with TIMI flow after
primary PCI (OR 0.8; p = 1,000) and the number of coronary vessel involvement
(OR 0.3; p = 0.163).
Conclusion: There were no relationship between the Gly972Arg polymorphism of
IRS1 gene with TIMI flow after primary PCI and the number of coronary vessel
involvement of STEMI patients.